Navigation Links
ABILIFY(R) (aripiprazole) Supplemental New Drug Application for the Treatment of Pediatric Patients with Bipolar I Disorder Accepted for Priority Review by the U.S. Food and Drug Administration
Date:11/15/2007

- Otsuka-sponsored Study Evaluated Use of ABILIFY in Patients Ages 10 to 17

-

TOKYO, Japan and PRINCETON, N.J., Nov. 15 /PRNewswire-FirstCall/ -- Otsuka Pharmaceutical Co., Ltd. and Bristol-Myers Squibb Company (NYSE: BMY) announced today that the U.S. Food and Drug Administration (FDA) has accepted for filing and granted a Priority Review to the supplemental New Drug Application (sNDA) of the atypical antipsychotic ABILIFY(R) (aripiprazole) for the treatment of pediatric patients (10 to 17 years old) diagnosed with Bipolar I Disorder, manic or mixed episode with or without psychotic features.

Priority Review status for an application or supplement for a drug product is assigned if a product, if approved, could represent an improvement compared to marketed products, including non-drug products/therapies in the treatment, diagnosis or prevention of a disease. The FDA goal for reviewing a drug with Priority Review is six months.

This sNDA is based on data from a multicenter, randomized, double-blind, placebo-controlled study of two fixed oral doses of ABILIFY (10 mg/day or 30 mg/day). The efficacy and safety of ABILIFY were assessed in 296 ethnically diverse pediatric patients (ages 10 to 17) with Bipolar I Disorder over a 30- week treatment timeframe, which consisted of a four-week double-blind acute phase, followed by a 26-week double-blind continuation phase. This trial was sponsored by Otsuka Pharmaceutical Co., Ltd. and its U.S. subsidiary, Otsuka Pharmaceutical Development & Commercialization, Inc. (Princeton, NJ) and was conducted at 54 centers in the U.S.

About ABILIFY(R) (aripiprazole)

The first and only available dopamine partial agonist, ABILIFY is indicated for the treatment of acute manic or mixed episodes associated with Bipolar I Disorder in adults. ABILIFY is also indicated for the treatment of schizophrenia in adults and adolescents (13 to 17 years old). ABILIFY(R) (aripiprazole)
'/>"/>

SOURCE Otsuka Pharmaceutical Co., Ltd.; Bristol-Myers SquibbCompany
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine news :

1. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for Adolescent Patients With Schizophrenia
2. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
3. Whites take supplemental breast cancer therapy more often than blacks
4. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
5. Investigational New Drug Application for Fat Melting Injections Cleared by the FDA
6. PreMD Provides Update on 510(k) Application for PREVU(x) POC
7. Mindray Selects Actel Low-Power Flash FPGAs for Demanding Medical Equipment Applications
8. Medical Services International Inc. Completes Testing for European Union (EU) Application
9. Pharsight Files Application for Nasdaq Capital Market Listing
10. PartsSource Awarded US Patent for PartsFinder(TM) Application
11. HealthCentral.com Launches Greeting Card Application on Facebook.com

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)... , CHICAGO Middle-aged men and women who engage ...ngly causing damage to their knees and increasing ...y presented today at the annual meeting of the Rad...r data suggest that people with higher physical ac...g knee abnormalities and, thus, at higher risk for...
(Date:11/30/2009)... , , DALLAS Nov. 30, 2009 UT Southwestern Medic...lts can help families stave off complications asso... and in the December issue of Pediatrics, sugges... of asthmatic children who have received specializ...ng, asthma attacks, emergency room visits and miss...
(Date:11/29/2009)... , The Academy of General...of Orange county CA, received the Mastership Award...cognizes AGD members, commitment to excellence in ...completed 1,100 hours of approved continuing denta...cluding 400 hours dedicated to hands-on skills and...
(Date:11/29/2009)... Witnessing someone get blamed for something lead...nds , , SUNDAY, Nov. 29 (HealthDay News)...y reports, even when the target is innocent. , ...me someone else for a problem, even if it,s an unf... in blaming others, too. , "When we see others...
(Date:11/29/2009)... , Traditional healthcare... for viable affordable alternative care. Affordabl... (PRWEB) November 29, 2009 -- A... June of this year (2009) and has been met with en...and rapid success can be attributed to two things,...
Breaking Medicine News(10 mins):Health News:Too much physical activity may lead to arthritis 2Health News:Parent mentors can improve the asthmatic care of minority children, UT Southwestern researchers find 2Health News:Orange County Dentist Honored by The Academy of General Dentistry 2Health News:When Accusations Start to Fly, They Multiply 2Health News:Affordable Acupuncture Greeted with Open Arms by Scottsdale and Phoenix Communities 2
...cademy,of Orthopaedic Surgeons (AAOS) has approved...guideline on "The Treatment of Carpal Tunnel Syndr...s CTS, is among the most,common disorders of the u...e median nerve in the carpal tunnel in the,wrist,"...
...urns Your Compassion into Life,Changing Solutions,...e long lines and steep price tags at the departmen...ers --- like helping a blind child in,Nepal see ag... season by sending Gifts of Service(R) cards from ...
...versity Cell and DNA Repository (RUCDR) has receiv...from the National Institutes of Health (NIH). One ...the other will support investigations into the cau...ntific merit of the proposals and the past experie...
...bout 5 million people in the United States suffer ...te that changes to diet can reduce HF risk, few la... new study researchers observed over 14,000 partic... groups did not directly affect HF risk. The resul...
...omberg School of Public Health have been selected ...o understand patterns of disability and aging. The...tional Institutes of Health, is expected to award ...f Medicine & Dentistry of New Jersey, Brown Univer...
...enefits to improve care and quality of life for M...ns -, COLUMBIA, S.C., Oct. 27 In preparation for...ich begins November 15th, Care,Improvement Plus to...hancements to added benefits and care management,s...
Other Medicine News:Health News:AAOS Issues New Treatment Guidelines for Carpal Tunnel Syndrome 2Health News:This Holiday Season, Give a Gift that Does a World of Good 2Health News:NIH awards Rutgers Cell and DNA Repository $57.8M 2Health News:Eating whole grains lowers heart failure risk, according to new study 2Health News:Bloomberg School of Public Health to lead nationwide aging study 2Health News:Care Improvement Plus Launches 2009 Benefits in South Carolina 2
(Date:11/29/2009)... FUJIFILM Medical Systems USA, Inc...ionary flat panel DR cassette, at the 2009 Radiolo...ng. Ideal for any clinical environment, FDR D-EVO...icians with Fujifilm,s trademark image quality and... way for users to transition to DR without modific...
(Date:11/29/2009)... Stimulated by the ten years of Sy...dical Systems USA announced today, at the Radiolog...g, the formation of its Medical Informatics Divis...w group will integrate all functions associated wi...a platform for future growth. ,, Several organi...
(Date:11/29/2009)... Researchers using functional magn...ation have found that men and women respond differ...to a study presented today at the annual meeting o.... ,, "Men may direct more attention to sensory ...hem in terms of implications for required action, ...
Breaking Medicine Technology:FUJIFILM's DR Cassette Makes World Debut 2FUJIFILM Establishes Medical Informatics Organization 2FUJIFILM Establishes Medical Informatics Organization 3New Study Finds Men and Women May Respond Differently to Danger 2New Study Finds Men and Women May Respond Differently to Danger 3Spaghetti scaffolding could help grow skin in labs 10400 1Spaghetti scaffolding could help grow skin in labs 10400 2Targacepts P 2b depression study succeeds 3A 6 point difference on HAM D 10395 1Targacepts P 2b depression study succeeds 3A 6 point difference on HAM D 10395 2Targacepts P 2b depression study succeeds 3A 6 point difference on HAM D 10395 3BCS Global Completes Polycom Telepresence VNOC 28Video Network Operations Center 29 Provider Program 59636 1BCS Global Completes Polycom Telepresence VNOC 28Video Network Operations Center 29 Provider Program 59636 2BCS Global Completes Polycom Telepresence VNOC 28Video Network Operations Center 29 Provider Program 59636 3
...SBROUCK HEIGHTS, N.J.--(BUSINESS WIRE)--Jun 21, 20...X) today announced that,detailed results from the ...r benign prostatic hyperplasia (BPH) will be prese..., beginning in September,at the South Central Amer...rings. These independent podium presentations will...
...HICAGO, June 21, 2007 /PRNewswire/ -- , What and W...of ACTOS(R),(pioglitazone HCl) will be presented i... the American Diabetes Association in,Chicago: , ,... in high-risk type 2, diabetes patients tre... PROactive; Poster 0553-P presented on Satur...
Other Medicine Technology:Nymox Announces NX-1207 Data to Be Presented at Upcoming U.S.,Urology Meetings 2MEDIA ADVISORY: Subsets of Landmark Diabetes Trials Investigating,MacroVascular Outcomes Presented at the American Diabetes,Association 67th Scientific Sessions 2MEDIA ADVISORY: Subsets of Landmark Diabetes Trials Investigating,MacroVascular Outcomes Presented at the American Diabetes,Association 67th Scientific Sessions 3
Three-mirror Contact Lens 907
Three-mirror Contact Lens 906
...l conditions in the area of the front of the iris....n only be ascertained by employing a narrow slit b...clinable illumination, is primarily capable of pro...angle of the iris, which is of special importance ...
Retrograde Nail
Medicine Products: